NAFLD in Asia—as common and important as in the West (original) (raw)
Ludwig, J., Viggiano, T. R., McGill, D. B. & Oh, B. J. Nonalcoholic steatohepatitis; Mayo experience with a hitherto unnamed disease. Mayo Clin. Proc.55, 434–438 (1980). CASPubMed Google Scholar
Yoshitoshi, Y. Clinical aspects of fatty liver [Japanese]. Chiryo46, 1–12 (1964). CASPubMed Google Scholar
Maruhama, Y. et al. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia. Diabetes27, 682–693 (1978). CASPubMed Google Scholar
Farrell, G. C. NASH: What is it, and why is it important in the Asia–Pacific region? J. Gastroenterol. Hepatol.18, 124–138 (2003). PubMed Google Scholar
Chitturi, S., Farrell, G. C. & George, J. Non-alcoholic steatohepatitis in the Asia–Pacific region: future shock? J. Gastroenterol. Hepatol.19, S242–S250 (2004). Google Scholar
Okanoue, T., Umemura, A., Yasui, K. & Itoh, Y. Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan. J. Gastroenterol. Hepatol.26 (Suppl. 1), S153–S163 (2011). Google Scholar
Chitturi, S., Wong V. W.-S. & Farrell, G. C. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. J. Gastroenterol. Hepatol.26 (Suppl. 1), S163–S172 (2011). Google Scholar
Wong, V. W. Non-alcoholic fatty liver disease in Asia–A story of growth. J. Gastroenterol. Hepatol.28, 18–23 (2013). PubMed Google Scholar
Chitturi, S. et al. Non-alcoholic fatty liver disease in the Asia–Pacific region: definitions and overview of proposed guidelines. J. Gastroenterol. Hepatol.22, 778–787 (2007). PubMed Google Scholar
Farrell, G. C. et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia–Pacific region. Executive Summary. J. Gastroenterol. Hepatol.22, 775–777 (2007). PubMed Google Scholar
Amarapurkar, D. N. et al. How common is non-alcoholic fatty liver disease in the Asia–Pacific region, and are there local differences? J. Gastroenterol. Hepatol.22, 788–793 (2007). PubMed Google Scholar
Fan J.-G. et al. What are the risk factors for non-alcoholic fatty liver disease in Asia–Pacific? J. Gastroenterol. Hepatol.22, 794–800 (2007). PubMed Google Scholar
Chan H. L, et al. How should we manage patients with non-alcoholic fatty liver disease in 2007? J. Gastroenterol. Hepatol.22, 801–808 (2007). PubMed Google Scholar
Ratzui, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position paper on NAFLD/NASH based on the EASL special conference. J. Hepatol.53, 372–384 (2010). Google Scholar
Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology55, 2005–2023 (2012). PubMed Google Scholar
Larter, C. Z., Chitturi, S., Heydet, D. & Farrell, G. C. A fresh look at NASH pathogenesis. Part 1: The metabolic movers. J. Gastroenterol. Hepatol.25, 672–690 (2010). CASPubMed Google Scholar
Angulo, P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology53, 1792–1794 (2011). PubMed Google Scholar
Dunn, W., Xu, R. & Schwimmer, J. B. Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease. Hepatology47, 1947–1954 (2008). PubMed Google Scholar
Dunn, W., et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J. Hepatol.57, 384–391 (2012). CASPubMedPubMed Central Google Scholar
Dixon, J. B., Bhathal, P. S. & O'Brien, P. E. Nonalcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology121, 91–100 (2001). CASPubMed Google Scholar
Davies, M. J. et al. Effects of moderate alcohol intake on fasting serum insulin and glucose concentrations and insulin sensitivity in postmenopausal women. JAMA287, 2559–2562 (2002). CASPubMed Google Scholar
Di Castelnuovo, A. et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch. Int. Med.166, 2437–2445 (2006). Google Scholar
Hamaguchi, M. et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J. Gastroenterol.18, 156–167 (2012). CASPubMedPubMed Central Google Scholar
Wong, V. W. et al. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol.56, 533–540 (2012). PubMed Google Scholar
Shi, J. P. et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J. Gastroenterol. Hepatol.23, 1419–1425 (2008). PubMed Google Scholar
Wong, G. L. et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut58, 111–117 (2009). PubMed Google Scholar
Yakoo, T., Tang, A. & Sirlin, C. in Non-alcoholic fatty liver disease. A practical guide (eds Farrell, G. C., Day, C. P., McCullough, A. J.) Wiley Blackwell 352 pages (in press).
Saadeh, S. et al. The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology123, 745–750 (2002). PubMed Google Scholar
Wong, V. W. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut61, 409–415 (2012). PubMed Google Scholar
Brunt, E. M. & Tiniakos, D. G. Histopathology of non-alcoholic fatty liver disease. World J. Gastroenterol.16, 5286–5296 (2010). PubMedPubMed Central Google Scholar
Neuschwander-Tetri, B. A. et al. Clinical, laboratory and histological associations in adults with non-alcoholic fatty liver disease. Hepatology52, 913–924 (2010). CASPubMed Google Scholar
Younossi, Z. M. et al. Pathologic criteria for non-alcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology53, 1874–1882 (2011). PubMed Google Scholar
Wong, V. W. et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology51, 454–462 (2010). CASPubMed Google Scholar
Wong, G. L. et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J. Gastroenterol. Hepatol.26, 300–305 (2011). PubMed Google Scholar
Hashimoto, E., Tokushige, K. & Farrell, G. C. Histological features of non-alcoholic fatty liver disease: what is important? J. Gastroenterol. Hepatol.27, 5–7 (2012). CASPubMed Google Scholar
Chalasani, N. et al. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J. Hepatol.48, 829–834 (2008). PubMedPubMed Central Google Scholar
Guy, C. D. et al. Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. Hum. Pathol.43, 790–800 (2012). CASPubMed Google Scholar
Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology44, 865–873 (2006). CASPubMed Google Scholar
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. & Caldwell, S. H. Systematic review of risk factors for fibrotic progression in non-alcoholic steatohepatitis. J. Hepatol.51, 371–379 (2009). CASPubMed Google Scholar
Adams, L. A., Sanderson, S., Lindor, K. D. & Angulo, P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol.42, 132–138 (2005). PubMed Google Scholar
Wong, V. W. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut59, 969–974 (2010). PubMed Google Scholar
Ratziu, V. et al. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment. Pharmacol. Ther.26, 821–830 (2007). CASPubMed Google Scholar
Bugianesi, E. et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology123, 134–140 (2002). PubMed Google Scholar
Caldwell, S. H. et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann. Hepatol.8, 346–352 (2009). PubMedPubMed Central Google Scholar
Lee, K. Relationship between uric acid and hepatic steatosis among Koreans. Diabetes Metab.35, 447–451 (2009). CASPubMed Google Scholar
Park, S. H. et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol.21, 138–143 (2006). PubMed Google Scholar
Li, Y., Xu, C., Yu, C., Xu, L. & Miao, M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J. Hepatol.50, 1029–1034 (2009). CASPubMed Google Scholar
Fan, J. G. & Farrell, G. C. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol.50, 204–210 (2009). PubMed Google Scholar
Chen, C. H. et al. Prevalence and etiology of elevated serum alanine aminotransferase in an adult population of Taiwan. J. Gastroenterol. Hepatol.22, 1482–1489 (2007). CASPubMed Google Scholar
Tsai, C. H., Li, T. C. & Lin, C. C. Metabolic syndrome as a risk factor for non-alcoholic fatty liver disease. South Med. J.101, 900–905 (2008). PubMed Google Scholar
Lin, Y. C., Chang, P. F., Yeh, S. J., Liu, K. & Chen, H. C. Risk factors for liver steatosis in obese children and adolescents. Pediatr. Neonatol.51, 149–154 (2010). PubMed Google Scholar
Lee, Y. S., Kek, B. L., Poh, L. K., Saw, S. M. & Loke, K. Y. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. J. Pediatr. Gastroenterol. Nutr.47, 172–178 (2008). CASPubMed Google Scholar
Fan, J. G. et al. Fatty liver and the metabolic syndrome among Shanghai adults. J. Gastroenterol. Hepatol.20, 1825–1832 (2005). PubMed Google Scholar
Mohan, V., Farooq, S., Deepa, M., Ravikumar, R. & Pitchumoni, C. S. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res. Clin. Pract.84, 84–91 (2009). CASPubMed Google Scholar
Das, K. et al. Nonobese population in a developing country has a high prevalence of non-alcoholic fatty liver and significant liver disease. Hepatology51, 1593–1602 (2010). CASPubMed Google Scholar
Dassanayake, A. S. et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J. Gastroenterol. Hepatol.24, 1284–1288 (2009). PubMed Google Scholar
Pinidiyapathirage, M. J. et al. Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res. Note4, 513 (2011). Google Scholar
Magosso, E. et al. Prevalence of non-alcoholic fatty liver in a hypercholesterolemic population of northwestern peninsula Malaysia. Southeast Asian J. Trop. Med. Public Health41, 936–942 (2010). PubMed Google Scholar
Malik, A., Cheah, P. L., Hilmi, I. N., Chap, S. P. & Goh, K. L. Non-alcoholic fatty liver disease in Malaysia a demographic, anthropometric, metabolic and histologic study. J. Dig Dis.8, 58–64 (2007). CASPubMed Google Scholar
Chow, W. C. et al. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. Singapore Med. J.48, 752–757 (2007). CASPubMed Google Scholar
Liu, C. J. Prevalence and risk factors for NAFLD in Asian people who are not obese. J. Gastroenterol. Hepatol.27, 1555–1560 (2012). PubMed Google Scholar
Yoon K.-H. et al. Epidemic obesity and type diabetes in Asia. Lancet368, 1681–1688 (2006). PubMed Google Scholar
Chang, Y. et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in health Korean men. Gut58, 1419–1425 (2009). CASPubMed Google Scholar
Park, S. H. et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J. Gastroenterol. Hepatol.19, 694–698 (2004). CASPubMed Google Scholar
Weston, S. R. et al. Racial and ethnic distribution of non-alcoholic fatty liver in persons with newly diagnosed liver disease. Hepatology41, 372–379 (2005). PubMed Google Scholar
Bambha, K. et al. Ethnicity and non-alcoholic fatty liver disease. Hepatology55, 769–780 (2012). CASPubMed Google Scholar
Urakami, T. et al. Insulin resistance at diagnosis in Japanese children with type 2 diabetes mellitus. Pediatr. Int.54, 516–519 (2012). CASPubMed Google Scholar
Williams, C. D. et al. Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology140, 124–131 (2011). PubMed Google Scholar
Cusi, K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis (NASH): clinical implications. Gastroenterology142, 711–725 (2012). CASPubMed Google Scholar
Hamaguchi, M. et al. The metabolic syndrome as a predictor of non-alcoholic fatty liver disease. Ann. Int. Med.143, 722–728 (2005). CASPubMed Google Scholar
Wong, V. W. et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther.24, 1215–1222 (2006). CASPubMed Google Scholar
Kimura, Y. et al. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. J. Gastroenterol. Hepatol.26, 517–522 (2011). CASPubMed Google Scholar
Manchanayake, J., Chitturi, S., Nolan, C. & Farrell, G. C. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol.26, 510–516 (2011). CASPubMed Google Scholar
Chitturi, S. et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology35, 373–379 (2002). CASPubMed Google Scholar
Anjana, R. M. et al. Parental history of type 2 diabetes mellitus, metabolic syndrome and cardiometabolic risk factors in Asian Indian adolescents. Metabolism58, 344–350 (2009). CASPubMed Google Scholar
Loomba, R. et al. Association between diabetes, family history of diabetes and risk of non-alcoholic steatohepatitis and fibrosis. Hepatology56, 943–951 (2012). PubMed Google Scholar
Yamada, T. et al. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J. Gastroenterol. Hepatol.25, 352–356 (2010). CASPubMed Google Scholar
Fan, J. G. & Farrell, G. C. Does non-alcoholic fatty liver disease predispose patients to type 2 diabetes in the absence of obesity? J. Gastroenterol.25, 223–225 (2010). CAS Google Scholar
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M. & Otsuki, M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care30, 2940–2944 (2007). CASPubMed Google Scholar
Fan, J. G. et al. Effects of non-alcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol.22, 1086–1091 (2007). CASPubMed Google Scholar
Sung, K. C., Jeong, W. S., Wild, S. H. & Byrne, C. D. Combined influence of insulin resistance/obesity and fatty liver as risk factors for type 2 diabetes. Diabetes Care35, 717–722 (2012). CASPubMedPubMed Central Google Scholar
Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology45, 846–854 (2007). CASPubMed Google Scholar
Tsang, S. W. et al. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol.21, 116–121 (2006). PubMed Google Scholar
Noto, H., Osame, K., Sasazuki, T. & Noda, M. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiological evidence in Japan. J. Diabetes Complications24, 345–353 (2010). PubMed Google Scholar
Lai, S. W. et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction with anti-diabetic therapy: a population-based cohort study. Am. J. Gastroenterol.107, 46–52 (2012). CASPubMed Google Scholar
Marchesini, G. & Forlani, G. Diabetes and hepatocellular carcinoma: not only a matter of hyperglycemia. Hepatology55, 1298–1300 (2012). PubMed Google Scholar
Musso, G., Cassader, M., Rosino, F. & Gambino, R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia55, 885–904 (2012). CASPubMed Google Scholar
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. & Lustig, R. H. The role of fructose in pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol.7, 251–264 (2010). CASPubMed Google Scholar
Abdelmalek, M. F. et al. Increased fructose consumption is associated with fibrosis severity in patients with non-alcoholic fatty liver disease. Hepatology51, 1961–1971 (2010). CASPubMed Google Scholar
Toshimitsu, K. et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition23, 46–52 (2007). PubMed Google Scholar
Enjoji, M. & Nakamuta, M. Is the control of dietary cholesterol intake sufficiently effective to ameliorate non-alcoholic fatty liver disease? World J. Gastroenterol.16, 800–803 (2010). CASPubMedPubMed Central Google Scholar
Ioannou, G. N., Morrow, O. B., Connole, M. L. & Lee, S. P. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology50, 175–184 (2009). CASPubMed Google Scholar
Farrell G. C. & van Rooyen, D. Liver cholesterol: is it playing possum in NASH? Am. J. Physiol. Gastrointest Liver Physiol.303, G9–G11 (2012). CASPubMed Google Scholar
Musso, G., Gambino, R. & Cassader, M. Cholesterol metabolism and the pathogenesis of non-alcoholic fatty liver disease. Prog. Lipid Res.52, 175–191 (2013). CASPubMed Google Scholar
Musso, G., Gambino, R., Cassader, M. & Pagano, G. A meta-analysis of randomized trials for the treatment of non-alcoholic fatty liver disease. Hepatology52, 79–104 (2010). CASPubMed Google Scholar
Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med.362, 1675–1685 (2010). CASPubMedPubMed Central Google Scholar
Kistler, K. D. et al. Physical activity recommendations, exercise intensity, and histological severity of non-alcoholic fatty liver disease. Am. J. Gastroenterol.106, 460–468 (2011). PubMedPubMed Central Google Scholar
Thoma, C. & Day, C. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J. Hepatol.56, 255–266 (2012). PubMed Google Scholar
Jin, J. Y. et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J. Gastroenterol. Hepatol.27, 1341–1347 (2012). CASPubMed Google Scholar
Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet.40, 1461–1465 (2008). CASPubMedPubMed Central Google Scholar
Speliotes, E. C. et al. Genome-wide association analysis identifies variants associated with non-alcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet.7, e1001324. (2011). CASPubMedPubMed Central Google Scholar
Romeo, S. et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J. Hepatol.53, 335–338 (2010). CASPubMed Google Scholar
Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of non-alcoholic fatty liver disease. Gastroenterology139, 1567–1576 (2010). PubMed Google Scholar
Chen, S., Li, Y., Li, S. & Yu, C. A Val227Ala substitution in the peroxisome proliferator activated receptor α (PPARα) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-hip-ratio. J. Gastroenterol. Hepatol.23, 1415–1418 (2008). CASPubMed Google Scholar
Yamakawa-Kobayashi, K., Ishiguro, H., Arinami, T., Miyakzaki, R. & Hamaguchi, H. A Val227Ala polymorphism in the peroxisome proliferator activated receptor α (PPARα) gene is associated with variations in serum lipid levels. J. Med. Genet.39, 189–191 (2002). CASPubMed Google Scholar
Adams, L. A. et al. Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity. J. Gastroenterol. Hepatol.27, 1520–1527 (2012). CASPubMed Google Scholar
Hui, Y. et al. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int.28, 385–392 (2008). PubMed Google Scholar
Chen, H. H., Lee, W. J., Fann, C. S., Bouchard, C. & Pan, W. H. Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese. Am. J. Clin. Nutr.90, 255–262 (2009). CASPubMed Google Scholar
Wang, C. W. et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and non-alcoholic fatty liver disease in a normoglycaemic population. Liver Int.31, 1326–1331 (2011). PubMed Google Scholar
Zain, S. M. et al. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum. Genet.131, 1145–1152 (2012). CASPubMedPubMed Central Google Scholar
Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology51, 1209–1217 (2010). CASPubMed Google Scholar
Duseja, A. & Aggarwal, R. ApoC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. J. Gastroenterol. Hepatol.27, 848–851 (2012). CASPubMed Google Scholar
Kawaguchi, T. et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE7, e38322 (2012). CASPubMedPubMed Central Google Scholar
Petersen K. F. et al. Apolipoprotein C3 gene variants in non-alcoholic fatty liver disease. N. Engl. J. Med.362, 1082–1089 (2010). CASPubMedPubMed Central Google Scholar
Valenti, L. et al. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol.12, 111 (2012). CASPubMedPubMed Central Google Scholar
Wong, V. W. et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol.4, 1154–1161 (2006). CASPubMed Google Scholar
Yuan, X. et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet.83, 520–528 (2008). CASPubMedPubMed Central Google Scholar
Stickel, F. & Hampe, J. Genetic determinants of alcoholic liver disease. Gut61, 150–159 (2012). CASPubMed Google Scholar
Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G. & Hinds, D. A. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet.42, 21–23 (2010). CASPubMed Google Scholar
Xin, Y. N. et al. Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity. Proteins81, 406–414 (2012). PubMed Google Scholar
Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Invest.122, 4130–4144 (2012). CASPubMedPubMed Central Google Scholar
Pirazzi, C. et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol.57, 1276–1282 (2012). CASPubMed Google Scholar
Wong, V. W. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut59, 969–974 (2010). PubMed Google Scholar
Jain, D., Nayak, N. C. & Saigal, S. Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients. Eur. J. Gastroenterol. Hepatol.24, 840–848 (2012). PubMed Google Scholar
Hashimoto, E. & Tokushige, K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic? Hepatol. Res.42, 1–14 (2012). PubMed Google Scholar
Ascha, M. S. et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology51, 1972–1978 (2010). PubMed Google Scholar
Bhala, N. et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology54, 1208–1216 (2011). PubMed Google Scholar
Cho, E. J. et al. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area. Digestion84 (Suppl 1.), 17–22 (2011). PubMed Google Scholar
Kawamura, Y. et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am. J. Gastroenterol.107, 253–261 (2012). CASPubMed Google Scholar
Adams, L. A. et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology129, 113–121 (2005). PubMed Google Scholar
Chitturi, S. & Farrell, G. C. Clues from the carotids: An appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol.24, 1311–1319 (2009). Google Scholar
Stepanova, M. & Younossi, Z. M. Independent association between non-alcoholic fatty liver disease and cardiovascular disease in the US population. Clin. Gastroenterol. Hepatol.10, 646–650 (2012). PubMed Google Scholar
Hsaio, P. J. et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol.22, 2118–2123 (2009). Google Scholar
Wang, C. C. et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol.24, 1411–1416 (2009). PubMed Google Scholar
Kim, D. et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology56, 605–613 (2012). CASPubMed Google Scholar
Kim, B. J., Kim, N. H., Kim, B. S. & Kang, J. H. The association between non-alcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology123, 54–61 (2012). PubMed Google Scholar
Wong, V. W. et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut60, 1721–1727 (2011). CASPubMed Google Scholar
Calle E. E, Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of, U. S. adults. N. Engl. J. Med.348, 1625–1638 (2003). PubMed Google Scholar
Hwang, S. T. et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J. Gastroenterol. Hepatol.27, 91–95 (2010). Google Scholar
Lee, Y. I., Lim, Y. S. & Park, H. S. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective study. J. Gastroenterol. Hepatol.25, 562–567 (2012). Google Scholar
Wong, V. W. et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut60, 829–836 (2011). PubMed Google Scholar
Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology51, 1820–1832 (2010). PubMed Google Scholar
Larsson, S. C. & Wolk, A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br. J. Cancer97, 1005–1008 (2007). CASPubMedPubMed Central Google Scholar
Chen, C. L. et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology135, 111–121 (2008). CASPubMed Google Scholar
Welzel, T. M. et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology54, 463–471 (2011). PubMed Google Scholar
Promrat, K. et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology51, 121–129 (2010). CASPubMed Google Scholar
Lindström, J. et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet368, 1673–1679 (2006). PubMed Google Scholar
Dixon, J. B., Bhathal, P. S. & O'Brien, P. E. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histological improvement. Obes. Surg.16, 1278–1286 (2008). Google Scholar
Mathurin, P. et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology137, 532–540 (2009). CASPubMed Google Scholar
Ratzui, V. et al. A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. J. Hepatol.57, 376–383 (2012). Google Scholar
Athyros, V. G. et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet376, 1916–1922 (2010). CASPubMed Google Scholar
Lonardo, A. & Loria, P. Potential for statins in the chemoprevention and management of hepatocellular carcinoma. J. Gastroenterol. Hepatol.27, 1654–1664 (2012). CASPubMed Google Scholar
Nielsen, S. F., Nordestgaard, B. G. & Bojesen, S. E. Statin use and reduced cancer-related mortality. N. Engl. J. Med.367, 1792–1802 (2012). CASPubMed Google Scholar
Park, H. et al. Efficacy of long-term ezetimibe therapy in patients with non-alcoholic fatty liver disease. J. Gastroenterol.46, 101–107 (2011). CASPubMed Google Scholar
Tanaka, N. et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol.42, 413–418 (2008). CASPubMed Google Scholar
Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C. & Sarin, S. K. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol.22, 634–638 (2007). CASPubMed Google Scholar
Chitturi, S. & Farrell, G. C. TNF-α as therapeutic target in NASH: tried, but not yet proven. J. Gastroenterol. Hepatol.22, 613–614 (2007). PubMed Google Scholar
Madan, K. et al. Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. Indian J. Gastroenterol.24, 251–255 (2005). PubMed Google Scholar
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I. & Terano, A. Plasma transforming growth factor-β1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment. Pharmacol. Ther.15, 1667–1672 (2001). CASPubMed Google Scholar
Wang, C. L. et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J. Gastroenterol.14, 1598–1602 (2008). CASPubMedPubMed Central Google Scholar
Ono, M. et al. Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones. Metabolism54, 529–532 (2005). CASPubMed Google Scholar
Hyogo, H. et al. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. Dig. Liver Dis.44, 492–496 (2012). CASPubMed Google Scholar
Iwasaki, T. et al. Sitagliptin as a novel treatment agent for non-alcoholic fatty liver disease patients with type 2 diabetes mellitus. Hepatogastroenterology58, 2103–2105 (2011). CASPubMed Google Scholar
Enjoji, M. et al. Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study. Int. J. Mol. Med.22, 521–527 (2008). CASPubMed Google Scholar
Zein, C. O. et al. Pentoxifylline improves non-alcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology54, 1610–1619 (2011). CASPubMed Google Scholar